cadenas
  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-032 BEACON

A randomised phase IIb trial of BEvACizumab added to Temozolomide ± IrinOtecan for children with refractory/relapsed Neuroblastoma

Promotor Name : CRCTU

Investigator Name : L. MORENO

Trial is registered on clinicaltrial.gov: NCT02308527